GDTC
GDTC
NASDAQ · Biotechnology

Cytomed Therapeutics Ltd

$0.84
+0.00 (+0.49%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,794.0% upside
Low Target $15.00
Average Target $24.31
High Target $29.94
Current Price $0.84
Current
$0.84
Target
$24.31
$15.00 $24.31 avg $29.94
Scenario Analysis
Bear Case
$15.00
1,685.7%
Low target
Base Case
$24.31
+2,794.0%
Avg target
Bull Case
$29.94
+3,464.3%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$3.10
-72.9% from high
52-Week Low
$0.68
+23.5% from low
Target vs 52W High
$24.31
+684.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%